Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 387

1.

Chagas disease. American trypanosomiasis.

Kirchhoff LV.

Infect Dis Clin North Am. 1993 Sep;7(3):487-502. Review.

PMID:
8254156
2.

[Chagas disease].

Develoux M, Lescure FX, Le Loup G, Pialoux G.

Rev Med Interne. 2009 Aug;30(8):686-95. doi: 10.1016/j.revmed.2008.11.010. Epub 2009 Feb 6. French.

PMID:
19201068
3.

Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).

Castro JA, de Mecca MM, Bartel LC.

Hum Exp Toxicol. 2006 Aug;25(8):471-9. Review.

PMID:
16937919
4.

American trypanosomiasis (Chagas disease).

Rassi A Jr, Rassi A, Marcondes de Rezende J.

Infect Dis Clin North Am. 2012 Jun;26(2):275-91. doi: 10.1016/j.idc.2012.03.002. Review.

PMID:
22632639
5.

Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives.

Braga MS, Lauria-Pires L, Argañaraz ER, Nascimento RJ, Teixeira AR.

Rev Inst Med Trop Sao Paulo. 2000 May-Jun;42(3):157-61.

6.

Antitrypanosomal therapy for chronic Chagas' disease.

Bern C.

N Engl J Med. 2011 Jun 30;364(26):2527-34. doi: 10.1056/NEJMct1014204. Review. No abstract available.

PMID:
21714649
7.

[Treatment of Chagas' disease].

Apt W.

Rev Med Chil. 1985 Feb;113(2):162-6. Spanish. No abstract available.

PMID:
3936147
8.

Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.

Murcia L, Carrilero B, Albajar Viñas P, Segovia M.

Rev Esp Quimioter. 2012 Mar;25(1):74-5. No abstract available.

9.

Recognizing and meeting the challenge of Chagas disease in the USA.

Bowling J, Walter EA.

Expert Rev Anti Infect Ther. 2009 Dec;7(10):1223-34. doi: 10.1586/eri.09.107. Review.

PMID:
19968514
10.

[Part VI. Antiparasitic treatment for Chagas disease].

B WA, G IH, L MI, M LJ, V PM, H IN, V AM, P JS, H MT, A IZ.

Rev Chilena Infectol. 2008 Oct;25(5):384-9, discussion 387. doi: /S0716-10182008000500013. Epub 2008 Oct 1. Spanish.

11.

Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina.

Sosa Estani S, Segura EL.

Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:363-5. Review. No abstract available.

12.
13.

[Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection].

[No authors listed]

Rev Soc Bras Med Trop. 2006 Jul-Aug;39(4):392-415. Portuguese. No abstract available.

14.
15.

Current status of Chagas disease chemotherapy.

Guedes PM, Silva GK, Gutierrez FR, Silva JS.

Expert Rev Anti Infect Ther. 2011 May;9(5):609-20. doi: 10.1586/eri.11.31. Review.

PMID:
21609270
16.

Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.

Okumura M, Mester M, Iriya K, Amato Neto V, Gama-Rodrigues J.

Transplant Proc. 1994 Jun;26(3):1587-9. No abstract available.

PMID:
8030049
17.

Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.

Yun O, Lima MA, Ellman T, Chambi W, Castillo S, Flevaud L, Roddy P, Parreño F, Albajar Viñas P, Palma PP.

PLoS Negl Trop Dis. 2009 Jul 7;3(7):e488. doi: 10.1371/journal.pntd.0000488.

18.

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.

Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A.

Expert Rev Anti Infect Ther. 2009 Mar;7(2):157-63. doi: 10.1586/14787210.7.2.157. Review.

PMID:
19254164
19.

Reversibility of muscle and heart lesions in chronic, Trypanosoma cruzi infected mice after late trypanomicidal treatment.

Segura MA, Molina de Raspi E, Basombrio MA.

Mem Inst Oswaldo Cruz. 1994 Apr-Jun;89(2):213-6.

Items per page

Supplemental Content

Write to the Help Desk